Amgen has denied a request by the FDA to voluntarily withdraw its rare disease drug Tavneos from the market, the company said ...

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM ...

Feb 4 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified Abbott's recall of certain glucose monitoring ...

The FDA has requested that Amgen voluntarily withdraw avacopan (Tavneos), a treatment for anti-neutrophil cytoplasmic ...

The Consolidated Appropriations Act of 2026, signed by Trump on Feb. 3, includes a provision reinstating the Mikaela Naylon ...

Rep. Jake Auchincloss of Massachusetts said the Commissioner’s National Priority Voucher program did not receive congressional backing. The FDA has also not yet made disclosures for eight senior ...

Feb 3 (Reuters) - AstraZeneca said on Tuesday the U.S. health regulator has rejected its application for a self-injectable ...

The Food and Drug Administration recalled a honey energy supplement on Wednesday after an undeclared erectile dysfunction medication was found in the product, the agency said. Ashfiat Alharamain ...

GelrinC, the only restorative product for knee cartilage repair, has CE Mark approval in Europe and is currently at the ...

A Las Vegas woman says she panicked after receiving a letter from Summerlin Hospital informing her that the facility's ...

The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...